Isoform Positions

Isoform Protein Position Transcript Position Chromosomal Position (HG38) Chromosomal Position (HG19)
IC34368103327;103328;103329 chr2:178533513;178533512;178533511chr2:179398240;179398239;179398238
N2AB3272798404;98405;98406 chr2:178533513;178533512;178533511chr2:179398240;179398239;179398238
N2A3180095623;95624;95625 chr2:178533513;178533512;178533511chr2:179398240;179398239;179398238
N2B2530376132;76133;76134 chr2:178533513;178533512;178533511chr2:179398240;179398239;179398238
Novex-12542876507;76508;76509 chr2:178533513;178533512;178533511chr2:179398240;179398239;179398238
Novex-22549576708;76709;76710 chr2:178533513;178533512;178533511chr2:179398240;179398239;179398238
Novex-3NoneNone chr2:Nonechr2:None

Information

  • RefSeq wild type amino acid: L
  • RefSeq wild type transcript codon: TTA
  • RefSeq wild type template codon: AAT
  • Domain: Ig-162
  • Domain position: 6
  • Structural Position: 7
  • Q(SASA): 0.5014
  • Predicted PPI site: I

Reported SAVs

SNV RS
DUET
PolyPhen-2
Condel
Rhapsody
REVEL
MVP
Source
MAF
Disease
Zygosity
Site annotation
mCSM PPI
Predicted PPI site
Comments
AFR
AMR
AMS
ASJ
EAS
EUR
FIN
MDE
NFE
SAS
OTH
L/S None None 0.997 N 0.804 0.555 0.834087401315 gnomAD-4.0.0 3.60097E-06 None None None None I None 0 0 None 0 0 None 0 0 3.9375E-06 0 0

Saturation Mutagenesis

SAV
AlphaMissense (IC)
AlphaMissense Class (IC)
AlphaMissense (N2AB)
AlphaMissense Class (N2AB)
mCSM
mCSM class
PolyPhen-2
PolyPhen-2 Class
Rhapsody
Rhapsody Class
Condel
Condel Score
Site annotation
mCSM PPI
Predicted PPI site
L/A 0.9314 likely_pathogenic 0.8651 pathogenic -1.033 Destabilizing 0.991 D 0.69 prob.neutral None None None None I
L/C 0.9781 likely_pathogenic 0.9555 pathogenic -0.771 Destabilizing 1.0 D 0.763 deleterious None None None None I
L/D 0.9961 likely_pathogenic 0.9897 pathogenic -0.118 Destabilizing 0.999 D 0.81 deleterious None None None None I
L/E 0.9771 likely_pathogenic 0.9477 pathogenic -0.113 Destabilizing 0.999 D 0.815 deleterious None None None None I
L/F 0.8286 likely_pathogenic 0.6888 pathogenic -0.57 Destabilizing 0.235 N 0.323 neutral N 0.495082733 None None I
L/G 0.9818 likely_pathogenic 0.9584 pathogenic -1.322 Destabilizing 0.998 D 0.81 deleterious None None None None I
L/H 0.9489 likely_pathogenic 0.8834 pathogenic -0.408 Destabilizing 1.0 D 0.776 deleterious None None None None I
L/I 0.5645 likely_pathogenic 0.4488 ambiguous -0.336 Destabilizing 0.955 D 0.471 neutral N 0.478209126 None None I
L/K 0.9061 likely_pathogenic 0.8406 pathogenic -0.566 Destabilizing 0.999 D 0.799 deleterious None None None None I
L/M 0.5465 ambiguous 0.4366 ambiguous -0.483 Destabilizing 0.998 D 0.688 prob.neutral None None None None I
L/N 0.967 likely_pathogenic 0.9322 pathogenic -0.463 Destabilizing 0.999 D 0.808 deleterious None None None None I
L/P 0.9238 likely_pathogenic 0.8266 pathogenic -0.535 Destabilizing 0.999 D 0.808 deleterious None None None None I
L/Q 0.9062 likely_pathogenic 0.8102 pathogenic -0.558 Destabilizing 1.0 D 0.799 deleterious None None None None I
L/R 0.8952 likely_pathogenic 0.7984 pathogenic -0.103 Destabilizing 0.999 D 0.811 deleterious None None None None I
L/S 0.9791 likely_pathogenic 0.947 pathogenic -1.087 Destabilizing 0.997 D 0.804 deleterious N 0.443229761 None None I
L/T 0.9406 likely_pathogenic 0.8853 pathogenic -0.954 Destabilizing 0.998 D 0.813 deleterious None None None None I
L/V 0.6438 likely_pathogenic 0.5022 ambiguous -0.535 Destabilizing 0.977 D 0.532 neutral N 0.44921437 None None I
L/W 0.9518 likely_pathogenic 0.8869 pathogenic -0.615 Destabilizing 1.0 D 0.778 deleterious None None None None I
L/Y 0.9512 likely_pathogenic 0.9035 pathogenic -0.374 Destabilizing 0.99 D 0.817 deleterious None None None None I

Titin has multiple isoforms, the longest being the theoretical IC (inferred complete) isoform which contains all 363 in-frame titin exons. Here all isoform positions have been mapped onto the IC sequence, with an exception being the C-terminal of the much shorter novex-3 isoform. This contains the out of frame exon 48 which cannot be mapped to the other isoforms.